OTSUKA AGURITEKUNO KABUSHIKI KAISHA – Trademark Portfolio

Entity Type: 03

OTSUKA AGURITEKUNO KABUSHIKI KAISHA holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include GATTEN, SCELTA, KALIGREEN, and ACARITOUCH. The owner is based in TOKYO.

2-2, KANDA TSUKASA-MACHI, CHIYODA-KU

TOKYO , JP

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCELTA
SCELTA
Registered 2011
GATTEN
GATTEN
Registered 2011
KALIGREEN
KALIGREEN
Registered 1996

Trademark Classifications

OTSUKA AGURITEKUNO KABUSHIKI KAISHA's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does OTSUKA AGURITEKUNO KABUSHIKI KAISHA have?

OTSUKA AGURITEKUNO KABUSHIKI KAISHA has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does OTSUKA AGURITEKUNO KABUSHIKI KAISHA file in?

OTSUKA AGURITEKUNO KABUSHIKI KAISHA files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are OTSUKA AGURITEKUNO KABUSHIKI KAISHA's most well-known trademarks?

OTSUKA AGURITEKUNO KABUSHIKI KAISHA's registered trademark portfolio includes well-known marks such as GATTEN, SCELTA, KALIGREEN, and ACARITOUCH. These are among 4 currently registered trademarks in the portfolio.

What is OTSUKA AGURITEKUNO KABUSHIKI KAISHA's trademark registration success rate?

OTSUKA AGURITEKUNO KABUSHIKI KAISHA has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.